Search Results - Thomas Dudler

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway–mediated disorders by Thomas Dudler, Sadam Yaseen, W. Jason Cummings

    Published in Frontiers in Immunology (2023-11-01)
    Get full text
    Article


  2. 2

    Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins by Youssif M. Ali, Youssif M. Ali, Matteo Ferrari, Nicholas J. Lynch, Sadam Yaseen, Thomas Dudler, Sasha Gragerov, Gregory Demopulos, Jonathan L. Heeney, Wilhelm J. Schwaeble

    Published in Frontiers in Immunology (2021-07-01)
    Get full text
    Article


  3. 3

    Inhibition of mannan-binding lectin associated serine protease (MASP)-2 reduces the cognitive deficits in a mouse model of severe traumatic brain injury by Domenico Mercurio, Francesca Pischiutta, Serena Seminara, Francesca Tribuzio, Ilaria Lisi, Laura Pasetto, Valentina Bonetto, Maria-Grazia De Simoni, Wilhelm Schwaeble, Sadam Yaseen, Thomas Dudler, Elisa R. Zanier, Stefano Fumagalli

    Published in Journal of Neuroinflammation (2024-05-01)
    Get full text
    Article


  4. 4

    The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection. by Youssif M Ali, Nicholas J Lynch, Kashif S Haleem, Teizo Fujita, Yuichi Endo, Soren Hansen, Uffe Holmskov, Kazue Takahashi, Gregory L Stahl, Thomas Dudler, Umakhanth V Girija, Russell Wallis, Aras Kadioglu, Cordula M Stover, Peter W Andrew, Wilhelm J Schwaeble

    Published in PLoS Pathogens (2012-01-01)
    Get full text
    Article


Search Tools: